PubMed · 12482739
Calcimimetics: therapeutic potential in hyperparathyroidism.
Abstract
Calcium homeostasis is essential for the normal function of many organ systems. The recently cloned extracellular calcium-sensing receptor plays a central role in this process and thus represents an important target for therapeutic agents aimed at treating disorders of calcium metabolism. Compounds, such as the phenylalkylamines NPS 568 and AMG 073, act as agonists of calcium at this receptor. These calcimimetic agents hold promise as potential treatments for diseases of parathyroid hyperfunction, such as primary and secondary hyperparathyroidism.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Adi Cohen, Shonni J Silverberg. 2002. Calcimimetics: therapeutic potential in hyperparathyroidism.. https://doi.org/10.1016/s1471-4892(02)00210-2
Cite the original work for its findings. Save a collection to share your selection of sources.